(Nasdaq: MYOK), today reported financial results ... Executive Director, Corporate Communications and Investor Relations ... Stern Investor Relations, Inc. 212-362- ...
Sep 11, 2020 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
People also ask
What is the revenue of MyoKardia?
Who is the founder of MyoKardia?
Who owns Mavacamten?
What is the medication for MyoKardia?
Myokardia Inc. Ticker MYOK. Exchange NASDAQ More ... Myokardia Inc reports have an aggregate usefulness score of 4.8 based on 92 reviews. ... Older/Archived Annual ...
Missing: investor relations
(Nasdaq: MYOK) today reported financial results ... Investor Relations contact at ir@myokardia.com. ... Stern Investor Relations, Inc. 212-362-1200. hannah ...
Oct 5, 2020 · Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash ; Investors: Tim Power, 609-252-7509, timothy.power@bms.com. Nina Goworek, ...
Oct 5, 2020 · Investors and MyoKardia stockholders are strongly advised to read the tender offer statement (including an offer to purchase, letter of ...
Missing: relations | Show results with:relations
Sep 13, 2019 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Bristol Myers Squibb has agreed to acquire MyoKardia, a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the ...
Aug 11, 2020 · Pioneering a Precision Approach to Cardiovascular Medicine Corporate Presentation - August 2020 forward-looking statement ...
Investor Relations: 1-877-208-7318. main content. Investor. Investor Story. Investor Story. ONEOK owns and operates one of the nation's premier natural gas ...
Missing: myok | Show results with:myok